-
Lennar Q3 Earnings & Revenues Beat, Stock Down on Tepid Q4 View
Friday, September 20, 2024 - 2:30pm | 1163Lennar Corporation (NYSE: LEN) reported third-quarter fiscal 2024 results, wherein its earnings and revenues surpassed the Zacks Consensus Estimate. On a year-over-year basis, revenues increased, given the company's emphasis on maintaining a steady production rate to drive sales momentum....
-
Homebuilder Lennar's Aggressive Capital Return Strategy: Higher Dividends And Massive Stock Buyback Program Underway
Wednesday, January 10, 2024 - 5:42am | 432Homebuilder Lennar Corp's (NYSE: LEN) Board of Directors has increased its annual dividend to $2.00 from $1.50 per share. The move will result in a quarterly cash dividend of $0.50 per share for both Class A and Class B common stock. The dividend is payable on February 7, 2024,...
-
Lennar's Agile Strategy In Challenging Market Yields Growth: Analyst Boosts Price Target By 10%
Tuesday, December 19, 2023 - 2:29pm | 504Raymond James analyst Buck Horne reiterated an Outperform rating on the shares of Lennar Corp (NYSE: LEN) raised the price target from $150 to $165. Lennar reported core EPS of $5.17 for its F4Q23 results, topping estimates of $4.59. Another upside quarterly result...
-
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Monday, September 25, 2023 - 12:04pm | 1511Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ: FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (...
-
Fed Countdown: Fireworks Lacking As Market Trades In Narrow Range Ahead Of Wednesday's Rate Decision
Tuesday, September 19, 2023 - 1:15pm | 2294(Tuesday market open) Narrow, choppy trading typical of the days approaching a Federal Reserve interest rate decision seems likely to continue Tuesday. The Fed meeting begins today and concludes tomorrow, with markets baking in a likely pause in rate hikes, yet investors remain on edge about...
-
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Tuesday, September 19, 2023 - 6:53am | 553Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37 in pre-market trading. B of A Securities slashed PTC Therapeutics, Inc. (NASDAQ: PTCT) price...
-
Govt Tried To Kill Housing: A Homebuilder Surprises With Q3 New Orders Up 37%
Friday, September 15, 2023 - 10:45am | 389Thursday after close, Lennar Corporation (NYSE: LEN) reported quarterly earnings of $3.91 per share, which beat the analyst consensus estimate of $3.51. Quarterly sales of $8.73 billion beat the analyst consensus estimate of $8.45 billion but fell 2.28% from the same period...
-
Full Plate: Lots To Digest As Investors Process Stronger-than-Expected PPI, Mixed Retail Sales
Thursday, September 14, 2023 - 10:55am | 2230(Thursday market open) A host of fresh economic data early Thursday showed the U.S. consumer and labor market remain in relatively good health, but wholesale inflation is ticking up a bit more than expected. The calculus isn’t likely to affect next week’s interest-rate decision...
-
Investor Sentiment Declines Further Following Inflation Data
Thursday, September 14, 2023 - 2:28am | 379The CNN Money Fear and Greed index showed further decline in overall sentiment among U.S. investors on Wednesday. U.S. stocks closed mixed on Wednesday, as investors digested hotter-than-expected inflation data for August. The annual inflation rate in the U.S. rose for a second consecutive month to...
-
Not A Four-Letter Word: "Risk" Embraced To Start Week Despite Rising Treasury Yields
Monday, September 11, 2023 - 12:37pm | 2461(Monday market open) After a lackluster start to the month, Wall Street turns its collective attention to critical U.S. inflation data and a European Central Bank (ECB) meeting later this week. Things are looking up so far as investors seem slightly less risk-averse this morning....
-
Trudge Into Weekend: Firm Dollar, Yields, And Crude Sink Markets As China Worries Persist For Tech
Friday, September 8, 2023 - 10:12am | 2115(Friday market open) This short week is starting to feel long, and for many investors it probably can’t end soon enough. Stocks around the world remained in the red early Friday and major U.S. indexes are on pace for more losses, hurt by the troika of rising yields, a firm dollar, and...
-
KB Home Constructs Bullish Price Action As Wider Industry Thrives
Thursday, August 17, 2023 - 10:24am | 884Homebuilders have been a leading industry throughout 2023, defying fears that high interest rates would keep buyers away. KB Home (NYSE: KBH), a mid-cap in the industry, has been forming a bullish area of price consolidation that might be hard to spot on a chart. KB Home is a component of the...
-
Strong Momentum In Homebuilding Industry: Raymond James' Take On Upgraded Ratings And Increased Price Targets
Friday, July 14, 2023 - 11:17am | 610Raymond James analyst Buck Horne raised the rating on several homebuilding stocks, given his bullish stance on homebuilding industry growth. Industry metrics: The analyst is upbeat on substantial homebuilders’ YTD stock performance and surprising declines in existing home inventory to...
-
ETF Returns: Mid-Cap Winners And Losers
Wednesday, June 28, 2023 - 3:16pm | 666We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on the week, according to data from etfdb.com. Only non-leveraged funds were considered. ...
-
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Tuesday, June 27, 2023 - 12:56pm | 1772Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti...